Imaging the Migraine Brain Pre- and Post-Erenumab
NCT03773562
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Migraine
Interventions
DRUG:
Erenumab
Sponsor
Mayo Clinic